2024 annual financial data

Tenaya Therapeutics 2024 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -115.95M USD and net income was -111.13M USD.
Operating cash flow was -90.5M USD.

Get free Tenaya Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-115.95M USD
Net income
-111.13M USD
Operating cash flow
-90.5M USD